TickerFacts.

A business in context

NTLA research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-08 · 8005 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-09-04 · 0001193125-26-383645 · Items 1.01,2.03,7.01,9.01

  2. 4 · Ownership change

    Report date 2026-08-20 · 0001193125-26-363567

  3. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-337952

  4. 8-K · Current report

    Report date 2026-08-06 · 0001193125-26-336772 · Items 2.02,9.01

  5. 4 · Ownership change

    Report date 2026-07-22 · 0001193125-26-316279

  6. 4 · Ownership change

    Report date 2026-07-01 · 0002019493-26-000002

  7. 4 · Ownership change

    Report date 2026-07-02 · 0001821530-26-000002

  8. 8-K · Current report

    Report date 2026-06-13 · 0001193125-26-270358 · Items 7.01,8.01,9.01

  9. 4 · Ownership change

    Report date 2026-06-09 · 0001756929-26-000002

  10. 4 · Ownership change

    Report date 2026-06-09 · 0001563572-26-000001

  11. 4 · Ownership change

    Report date 2026-06-09 · 0001545794-26-000001

  12. 4 · Ownership change

    Report date 2026-06-09 · 0001193125-26-266241

  13. 8-K · Current report

    Report date 2026-06-09 · 0001193125-26-265934 · Items 5.07

  14. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-215740

  15. 8-K · Current report

    Report date 2026-05-11 · 0001193125-26-215721 · Items 2.02,9.01

  16. 8-K · Current report

    Report date 2026-04-27 · 0001193125-26-197489 · Items 1.01,2.02,9.01

  17. DEF 14A · Proxy statement

    Report date 2026-06-09 · 0001193125-26-197283

  18. 8-K · Current report

    Report date 2026-04-27 · 0001193125-26-179401 · Items 7.01,8.01,9.01

  19. 8-K · Current report

    Report date 2026-04-07 · 0001193125-26-151300 · Items 5.03,9.01

  20. 8-K · Current report

    Report date 2026-03-02 · 0001193125-26-084309 · Items 1.01,7.01,8.01,9.01

  21. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-076550

  22. 8-K · Current report

    Report date 2026-02-26 · 0001193125-26-073456 · Items 2.02,9.01

  23. 8-K · Current report

    Report date 2026-01-27 · 0001193125-26-023387 · Items 7.01,8.01,9.01

  24. 8-K · Current report

    Report date 2026-01-09 · 0001193125-26-008307 · Items 7.01,8.01,9.01

  25. 8-K · Current report

    Report date 2025-11-08 · 0001193125-25-274596 · Items 7.01,8.01,9.01

  26. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-269680

  27. 8-K · Current report

    Report date 2025-11-06 · 0001193125-25-269479 · Items 2.02,9.01

  28. 8-K · Current report

    Report date 2025-10-29 · 0001193125-25-256378 · Items 8.01

  29. 8-K · Current report

    Report date 2025-10-27 · 0001193125-25-250757 · Items 7.01,8.01,9.01

  30. 8-K · Current report

    Report date 2025-09-25 · 0001193125-25-217484 · Items 7.01,8.01,9.01

  31. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-104987

  32. 8-K · Current report

    Report date 2025-08-07 · 0000950170-25-104574 · Items 2.02,5.02,9.01

  33. 8-K · Current report

    Report date 2025-06-15 · 0001193125-25-141087 · Items 7.01,8.01,9.01

  34. 8-K · Current report

    Report date 2025-06-11 · 0000950170-25-085479 · Items 5.02,5.07,9.01

  35. 8-K · Current report

    Report date 2025-05-28 · 0001193125-25-129524 · Items 7.01,8.01

  36. 8-K · Current report

    Report date 2025-05-18 · 0001193125-25-122076 · Items 7.01,8.01,9.01

  37. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-066914

  38. 8-K · Current report

    Report date 2025-05-08 · 0000950170-25-066403 · Items 2.02,9.01

  39. DEF 14A · Proxy statement

    Report date 2025-06-11 · 0000950170-25-061023

  40. 8-K · Current report

    Report date 2025-04-03 · 0001193125-25-073904 · Items 5.03,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 14 transaction rows14AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

14 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-09
2026-06-10
GOODMAN JESSEA · Grant / award
Acquired
Common Stock9200.00.0
2026-06-09
2026-06-10
GOODMAN JESSEA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
13300.00.0
2026-06-09
2026-06-10
CHASE WILLIAM JA · Grant / award
Acquired
Common Stock9200.00.0
2026-06-09
2026-06-10
CHASE WILLIAM JA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
13300.00.0
2026-06-09
2026-06-10
Verwiel FrankA · Grant / award
Acquired
Common Stock9200.00.0
2026-06-09
2026-06-10
Verwiel FrankA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
13300.00.0
2026-06-09
2026-06-10
Keresty GeorgiaA · Grant / award
Acquired
Common Stock9200.00.0
2026-06-09
2026-06-10
Keresty GeorgiaA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
13300.00.0
2026-06-09
2026-06-10
Goff BrianA · Grant / award
Acquired
Common Stock9200.00.0
2026-06-09
2026-06-10
Goff BrianA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
13300.00.0
2026-06-09
2026-06-10
Cohen Fred EA · Grant / award
Acquired
Common Stock9200.00.0
2026-06-09
2026-06-10
Cohen Fred EA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
13300.00.0
2026-06-09
2026-06-10
Bhanji MunaA · Grant / award
Acquired
Common Stock9200.00.0
2026-06-09
2026-06-10
Bhanji MunaA · Grant / award
Acquired
Stock Option (right to buy)
Derivative security
13300.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001652130Intellia Therapeutics, Inc.

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
5493002T5BCPE5DZC723
GLEIF legal name
INTELLIA THERAPEUTICS, INC.
Entity / LEI registration status
ACTIVE / LAPSED
Reference data updated
2026-09-01T23:30:21Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Intellia Therapeutics · alias · wikidata
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$57.88M$61.61M
2023-12-31$36.27M$39.75M
2022-12-31$52.12M$59.46M
2021-12-31$33.05M$40.72M
2020-12-31$57.99M$74.82M
2019-12-31$43.10M$56.29M
2018-12-31$30.43M$40.47M
2017-12-31$26.12M$35.58M

Bureau of Labor Statistics · retrieved 2026-09-08 · 9 selected series; gaps remain missing

Explore the CPI history ↗